Arkolith/Insider Trading/CRGX/Form 4

Orwin John A

DirectorCARGO Therapeutics, Inc. (CRGX) · full profile →Form 4 · filed Aug 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2025Disposed to issuer(D)25K——0
Aug 19, 2025Disposed to issuer(D)16K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-25-000302) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML